PEA in Functional Dyspepsia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The goal of this placebo controlled randomized double blind interventional study is to assess the effect of palmitoylethanolamide supplementation in patients with functional dyspepsia The main questions it aims to answer are: * The efficacy of PEA on functional dyspepsia symptoms measured using the LPDS questionnaire * The effect of PEA on duodenal mucosal permeability. Participants will receive an 8-week during treatment with PEA 3x400 mg per day or placebo 3 times per day.
Epistemonikos ID: 5051ddbb3bb52aa1a5e9b07ead697da28a6ad7bd
First added on: Feb 19, 2024